Free Cancer Report

Book Appointment with Dr Srinivasa B J in Bangalore

Dr Srinivasa B J

Medical Oncologist

6 Years Exp. Bangalore

Breast Cancer

HCG Cancer Centre, Kalinga Rao Road, Bangalore

6 years of experience

MBBS, MD, DNB

Bangalore

About Dr Srinivasa B J:

Dr Srinivas B J is a well-known doctor based in Bangalore who specialises in Oncology.He has over 6 years of experience practising medicine in various hospitals and clinics.He has vast experience in the field of Medical Oncology and his key areas of interest are Breast Cancer, GI Cancer, Lymphoma, and Myeloma. He is involved in Genomic-based cancer treatment that brings in precision care in diagnosis and management of cancer. He is currently involved in clinical trials as Primary Investigator for different cancers and has various publications to his credit. He is an active advocate for cancer awareness programmes. He has also been awarded the 'President NBE Goldmedal' with certification by the National Board of Examination, New Delhi for securing the highest marks in the medical Oncology examination. Dr Srinivas B J currently works at HCG, Bangalore.

Education:

MBBS - Bangalore Medical College and Research Institute, Bangalore, 2000 MD - General Medicine - MP Shah Medical College,Jamnagar, 2005 DNB - Medical Oncology - National Board Of Examination, 2014

Experience:

2014 - 2016 Consultant Medical Oncologist at HCG, Bangalore 2005 - 2007 Consultant at Manipal Hospital 2008 - 2009 Assistant Professor at Father Muller Medical college 2009 - 2011 Consultant at Vattsalya hospital

Memberships:

Bangalore Oncology Group

Areas of interest:

Breast Cancer, Lymphoma, Gastrointestinal (GI) Cancer, Myeloma.

Research publications:

484PActivity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials 503PActivity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials P2.01-99 A Phase IIIb Open-Label Study of Afatinib in EGFR TKI-Na•ve Patients with EGFR Mutation-Positive NSCLC: Final Analysis

Specialisation

Breast Cancer, Lymphoma, Gastrointestinal (GI) Cancer, Myeloma.